Skip to main content
. 2020 Nov 9;21(21):8411. doi: 10.3390/ijms21218411
APS antiphospholipid syndrome
OAPS obstetric antiphospholipid antibodies syndrome
IUGR intrauterine growth restriction
CAPS catastrophic antiphospholipid antibodies syndrome
SN-APS seronegative antiphospholipid antibodies syndrome
aPL antiphospholipid antibodies
β2-GPI beta2-glycoprotein I
anti-β2GPI DI anti-beta2-glycoprotein I domain I
CL Cardiolipin
PT/PS prothrombin/phosphatidylserine
LBPA lysobisphosphatidic acid
PE phosphatidylethanolamine
TLC thin layer chromatographic plates
PTMs post-translational modifications
ROS reactive oxygen species
ECs endothelial cells
TLR-4 Toll-like receptor 4
ApoER2 apolipoprotein E receptor 2
MyD88 myeloid differentiation factor 88
IRAK interleukin-1 receptor-associated kinase 1
MAPK mitogen-activated protein kinase
NF-κB nuclear factor kappa B
TF Tissue Factor
V-CAM vascular cell adhesion molecule-1
I-CAM intercellular cell adhesion molecule-1
mTOR mechanistic target of rapamycin
NETs neutrophil extracellular traps